Chunliang Liu Selected Research

Chunliang Liu Research Topics

Disease

17	Neoplasms (Cancer) 12/2023 - 12/2011
5	Carcinogenesis 08/2023 - 01/2017
5	Neoplasm Metastasis (Metastasis) 10/2022 - 09/2017
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 08/2023 - 01/2017
4	Breast Neoplasms (Breast Cancer) 08/2021 - 12/2011
3	Hepatocellular Carcinoma (Hepatoma) 11/2022 - 04/2018
3	Inflammation (Inflammations) 10/2022 - 01/2016
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2019 - 01/2017
2	Hemorrhage 03/2024 - 11/2018
2	Thrombocytopenia (Thrombopenia) 01/2024 - 11/2018
2	Cognitive Dysfunction 01/2022 - 01/2020
1	Polyploidy 01/2024
1	cyclic Thrombocytopenia 12/2023
1	Cholecystitis 10/2022
1	Hepatitis B 01/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021
1	Neuroinflammatory Diseases 01/2020
1	Papillomavirus Infections 03/2019
1	Infections 03/2019
1	Pain (Aches) 01/2019
1	Bone Neoplasms (Bone Cancer) 01/2019
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 11/2018
1	Uterine Cervical Dysplasia 02/2018
1	Colorectal Neoplasms (Colorectal Cancer) 01/2018
1	Leukemia 06/2015
1	Squamous Cell Carcinoma of Head and Neck 12/2011
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2010

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 12/2022 - 12/2016
4	EnzymesIBA 11/2022 - 09/2017
4	polylactosamineIBA 04/2018 - 06/2015
4	Polysaccharides (Glycans)IBA 04/2018 - 06/2015
3	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 09/2017
2	PotassiumIBA 12/2023 - 12/2022
2	Estradiol (Delestrogen)FDA LinkGeneric 12/2023 - 03/2019
2	RNA (Ribonucleic Acid)IBA 10/2022 - 01/2022
2	Sevoflurane (Ultane)FDA LinkGeneric 01/2022 - 01/2020
2	Messenger RNA (mRNA)IBA 01/2022 - 02/2018
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021 - 01/2021
2	CytokinesIBA 01/2020 - 01/2016
2	Antineoplastic Agents (Antineoplastics)IBA 06/2017 - 06/2015
1	NitrogenIBA 03/2024
1	CreatinineIBA 03/2024
1	Hemoglobins (Hemoglobin)IBA 03/2024
1	Urea (Carbamide)FDA LinkGeneric 03/2024
1	2- (1- (3- dimethylaminopropyl)- 5- methoxyindol- 3- yl)- 3- (1H- indol- 3- yl)maleimideIBA 01/2024
1	Cytidine Triphosphate (CTP)IBA 12/2023
1	Heterogeneous-Nuclear Ribonucleoprotein KIBA 08/2023
1	Ion Channels (Ion Channel)IBA 12/2022
1	NucleotidesIBA 11/2022
1	Ribose (D-Ribose)IBA 11/2022
1	TransketolaseIBA 11/2022
1	5,7- dihydroxy- 6- methoxy- 2- phenylchromen- 4- oneIBA 11/2022
1	SeleniumIBA 05/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	CalpainIBA 01/2022
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2022
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2022
1	Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA 01/2022
1	RoflumilastIBA 01/2022
1	EsketamineIBA 08/2021
1	Interleukin-8 (Interleukin 8)IBA 01/2021
1	Cadherins (E-Cadherin)IBA 01/2021
1	AntioxidantsIBA 01/2020
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2020
1	Small Interfering RNA (siRNA)IBA 01/2019
1	AutoantibodiesIBA 11/2018
1	Inosine Triphosphate (ITP)IBA 11/2018
1	Histidine (L-Histidine)FDA Link 02/2018
1	Folic Acid (Vitamin M)FDA LinkGeneric 02/2018
1	Folate Receptor 1IBA 01/2017
1	Proto-Oncogene Proteins c-junIBA 01/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2016
1	OligosaccharidesIBA 06/2015
1	Polypeptide N-acetylgalactosaminyltransferaseIBA 12/2011
1	MucinsIBA 12/2011
1	Interleukin-15 (Interleukin 15)IBA 10/2010

Therapy/Procedure

7	Therapeutics 12/2023 - 12/2016
1	Radiotherapy 01/2024
1	Immunotherapy 01/2022
1	Intraperitoneal Injections 01/2020
1	Tibetan Traditional Medicine (Traditional Tibetan Medicine) 06/2015